Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 30, 2024Journal of RetinaOpen Access

Two-year Outcome of Intravitreal Anti-vascular Endothelial Growth Factor Therapy for Polypoidal Choroidal Vasculopathy

View Full Paper
Ask AI
Bookmark
Share

Authors

YYYi Sang YoonCKChul Gu KimJKJong Woo KimUniversity of Seoul

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Yoon et al. (2024) studied this question.

synapsesocial.com/papers/68e67bb1b6db643587605db1https://doi.org/10.21561/jor.2024.9.1.73
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY1995 · 613 citations
  2. 2Results of 2 years of treatment with as-needed ranibizumab reinjection for polypoidal choroidal vasculopathy2013 · 54 citations
  3. 3Twenty‐four‐month real‐life treatment outcomes of polypoidal choroidal vasculopathy versus type 1 macular neovascularization in Caucasians2023 · 5 citations
  4. 4TIME TO FIRST TREATMENT2011 · 62 citations